RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

Chapman, MA; Sive, J; Ambrose, J; Roddie, C; Counsell, N; Lach, A; Abbasian, M; ... Yong, K; + view all Chapman, MA; Sive, J; Ambrose, J; Roddie, C; Counsell, N; Lach, A; Abbasian, M; Popat, R; Cavenagh, JD; Oakervee, H; Streetly, MJ; Schey, S; Koh, M; Willis, F; Virchis, AE; Crowe, J; Quinn, MF; Cook, G; Crawley, CR; Pratt, G; Cook, M; Braganza, N; Adedayo, T; Smith, P; Clifton-Hadley, L; Owen, RG; Sonneveld, P; Keats, JJ; Herrero, J; Yong, K; - view fewer (2018) RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature. Blood 10.1182/blood-2018-05-849893 . (In press).

https://ift.tt/2QWsTg9